Enantios
Drug Discovery
Overview
Discover how our cutting-edge measurement technology accelerates drug discovery by unlocking the structure of complex molecules and biologics.
Funding and backers
Backers
1
Privilege Ventures
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
backs Orbis Medicines
backs Metanova Labs
Similar startupsby what they do, their industry and backers
SYNthesis Med Chem is a global provider of small molecule drug discovery services and offers a unique support to drug discovery projects.
Regor combines a cutting-edge drug discovery engine with target validation and optimization for preclinical candidates in metabolism…
Turbine is virtualizing biological experiments with AI to accelerate drug discovery and enhance clinical translatability.
Solutions for drug discovery and diagnostics. SPR analysis, antibody selection and LFA services. K-One sensor chips & bioconjugates supply.
Oral biologics, solved with intelligent chemistry. Powered by nGen, our discovery platform, we are pioneering a new modality: nCycle based…
Light Horse is a small molecule drug discovery company that is leading the way in a.
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Privilege VenturesVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Behind the Technology: The Story of ECam
A key innovation inside the Enantios Gen 1 ROA instrument is our custom imaging system - ECam (Enantios Cam) - the engine that enables high-sensitivity, high-stability Raman Optical Activity measurements. What makes ECam special? It builds on the heritage
Read more
Report
Remote ROA Measurements? Yes - it's real
Today we're excited to share a behind-the-scenes look at one of the most powerful features of the Enantios Gen 1 ROA instrument: full remote access and control. In the video below, you'll see how users can: Log into the instrument from anywhere in the wor
Read more
Report
Chirality isn't just a scientific detail - it's a strategic lever in drug development!
Veranova's expert article is a good reminder of this and worth sharing here! The importance of chirality in API development - Veronova The ability to reliably deliver enantiopure APIs affects everything from regulatory timelines to patient safety and mark
Read more
Report
What actually goes into CE certification?
Spoiler: a lot more abuse than you might expect. At Enantios, we've completed the full CE compliance process for our Gen 1 ROA instrument - and we're excited to share a glimpse of what that meant behind the scenes. To meet CE standards, our system had to
Read more
Report
Big News from Enantios!
We're proud to share that the Enantios Gen 1 ROA Instrument is now officially CE certified - a major milestone that reflects our commitment to building reliable, industry-ready analytical technology for pharmaceutical and biotech innovators. This certific
Read more
Report
Another proud moment for ENANTIOS at SLUSH 2025!
Thrilled to share that ENANTIOS has won the Deep Tech Battle - HealthTech category at the Slush Conference in Helsinki! This recognition means a lot to us. It validates the hard work our team has poured into building frontier technology for next-generatio
Read more
Report
When Chirality Fails: What Happens When the Industry's "Solved Problem" Isn't?
Two global suppliers. Two incorrect products. One simple question: Is chirality really a solved problem? Raman Optical Activity (ROA) gave the right answer- instantly. This isn't just a story about mislabeling; it's a wake-up call for analytical chemistry
Read more
Report
We're excited to announce that ENANTIOS has emerged as a Grand Finalist at the 12th Lee Kuan Yew Global Business Plan Competition (LKYGBPC)!
This September, Dr. Carin Lightner and Dr. Roman Wyss will be visiting Singapore Management University, joining fellow next-gen innovators for #OneEpicShowdown in the collective fight against global crises in Urban Solutions & Sustainability. If our journ
Read more
Report
ENANTIOS will be attending some of the most important events in the life sciences and pharmaceutical industries this year
ILMAC Basel 2025 September 16-18, 2025 Messe Basel, Switzerland BIOSPAIN 2025 October 7-9, 2025 Fira de Barcelona - Montjuïc, Spain CPhI Worldwide 2025 October 28-30, 2025 Messe Frankfurt, Germany BIO-Europe 2025 November 3-5, 2025 Vienna Congress and Con
Read more
Report
Top three finalists!
ENANTIOS did it again! Swiss Excellence Award! Thank you for an amazing celebration!
Read more
Report